GISMO - Geographical Information Support for Healthy Mobility

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03098719
• Date of registration: 18/03/2017
• Prospective Registration: Yes
• Primary sponsor: Paracelsus Medical University
• Public title: GISMO - Geographical Information Support for Healthy Mobility GISMO
• Scientific title: GISMO - Geographical Information Support for Healthy Mobility
• Date of first enrolment: March 20, 2017
• Target sample size: 70
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03098719
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).
• Phase: N/A

Countries of recruitment

Austria

Key inclusion & exclusion criteria

Inclusion Criteria:

- employees of SALK (possibly also employees of other companies), age 18-70 voluntary
participation in the study, consent in German language, desire to change the currently
prevailing passive mobility behavior.

Exclusion Criteria:

- physical or psychological condition that makes the participation and completion of the
study unlikely. i.e.:

- Participation in further clinical trials at the same time, or at least four weeks
time

- Pregnancy or lactation

- Well-known diseases of the movement apparatus, which could influence healthy
mobility

- Subjects with known endogenous or reactive depression or other psychiatric
disorders such as panic disorder, schizophrenia, organic mental disorder,
delirious, psychotic, phobic, or other psychiatric disorder in the last five
years prior to study inclusion

- Subjects with osteoporosis requiring treatment

- Severe general disease (e.g., neoplasia, tuberculosis, heart failure)

- Subjects with chronic infections

- subjects with alcohol or drug abuse or dependency



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All

Health Condition(s) or Problem(s) studied

Health Behavior

Intervention(s)

Behavioral: Active Mobility

Primary Outcome(s)

Cardiorespiratory Fitness, i.e. metaboloic equivalents (METs) [Time Frame: 1 year]

Secondary Outcome(s)

Cardiovascular Risk [Time Frame: 1 year]

Secondary ID(s)

GISMO-1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University of Salzburg